Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The gamma-hydroxybutyric acid receptor (GHBR) is an excitatory G protein-coupled receptor that binds the endogenous neurotransmitter gamma-hydroxybutyric acid (GHB). It is distinct from the GABA_B receptor and mediates stimulant effects through increased Na+/K+ currents and neurotransmitter release. The receptor has approximately 11 transmembrane helices and is expressed in various brain regions, including the dentate gyrus, thalamus, and cerebellum. It plays a role in regulating neurotransmitter systems, sleep, mood, and anxiety.
Activation leads to increased Na+/K+ current and enhanced release of dopamine and glutamate, resulting in stimulant effects. May also enhance tryptophan transport and modulate oxytocinergic neuron activity.
13 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gamma-hydroxybutyric acid receptor (None).